melanotan 1 uses (MT1) 10mg | USA | CAS 75921-69-6 Melanotan 1 - Research Peptide
Description
LA-AG, Larch Wood Arabinogalactan
A study of CSP on plasma LC concentration and urinary excretion showed a 30% increase in total carnitine plasma concentration upon treatment that normalized within 7 days after cessation of treatment [95]
Comprehensive insight into colorectal cancer metabolites and lipids for human serum: A proof-of-concept study
However, there is currently no specific scientific research confirming a synergistic effect between these two compounds
(PubMed) Abam E, Okediran BS, Odukoya OO, Adamson I, Ademuyiwa O
